NCT05507073

Brief Summary

Single-blinded randomised controlled trial comparing impingement with CT scan for manual and robotic total hip replacement. A pilot study of 50 participants.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 6, 2021

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 27, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 18, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

September 8, 2023

Status Verified

August 1, 2023

Enrollment Period

3.7 years

First QC Date

June 27, 2022

Last Update Submit

September 7, 2023

Conditions

Keywords

hip replacementTHRRoboticArthroplastyHip SurgeryRange of Motion

Outcome Measures

Primary Outcomes (1)

  • Impingement analysis by a CT guided software in all participants to enable a comparison of post-operative impingement between robotic THR and manual THR

    To compare efficacy of Robotic THR in reducing post-operative impingement with Standard Manual THR

    6 weeks post-intervention

Secondary Outcomes (6)

  • Using the Forgotten Joint Score (FJS-12) to determine improvement in Patient reported outcome measures

    12 months

  • Using the Oxford Hip score to determine improvement in Patient reported outcome measures

    12 months

  • Using the EuroQol 5-D (EQ5-D) to determine improvement in Patient reported outcome measures

    12 months

  • Measure leg length following surgery to determine whether robotic THR or manual THR is more effective at reducing leg length discrepancy.

    12 months

  • Measure the duration of surgery and compare the duration of robotic THR to manual THR

    During Surgery

  • +1 more secondary outcomes

Study Arms (2)

Manual Total Hip Replacement

ACTIVE COMPARATOR

Manual Total Hip Replacement

Procedure: Manual Total Hip Replacement

Robot-Assisted Total Hip Replacement

EXPERIMENTAL

Robot-Assisted Total Hip Replacement

Procedure: Robot-Assisted Total Hip Replacement

Interventions

Implantation of a hip Device to alleviate pain and recover range of movement

Also known as: Hip Arthroplasty, Hip Replacement, Total Hip Replacement
Manual Total Hip Replacement

Robot assisted Implantation of a hip Device to alleviate pain and recover range of movement

Also known as: Hip replacement, Robotic Hip replacement, Robot Assisted Hip Arthroplasty
Robot-Assisted Total Hip Replacement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant is willing and able to give informed consent for participation in the trial
  • Male or Female, aged 18 to 85 years at recruitment into trial
  • Diagnosed with hip OA, post-traumatic OA, inflammatory arthropathy, , or congenital or developmental hip disease, avascular necrosis of the hip
  • Listed for total hip replacement
  • Suitable for Accolade 2 stem and Trident cup prostheses
  • Female participants of child bearing potential must be willing to ensure that they use effective contraception during the trial
  • In the Investigator's opinion, is able and willing to comply with all trial requirements
  • Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the trial.

You may not qualify if:

  • Inability to provide informed consent
  • Previous surgery to the ipsilateral hip and implantation of metalwork.
  • Significant co-morbidities that would make follow up difficult or uncomfortable
  • Scheduled elective surgery or other procedures requiring general anaesthesia during the trial.
  • Pregnancy or intention to become pregnant within the trial period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Royal Orthopaedic Hospital NHS Trust

Birmingham, United Kingdom

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, HipArthritis

Interventions

Arthroplasty, Replacement, Hip

Condition Hierarchy (Ancestors)

OsteoarthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Central Study Contacts

Edward T Davis, MD

CONTACT

Sam C Papadopoullos, BSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Individual/s carrying out assessment post-intervention are not aware of the intervention allocation
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This will be a two-arm, single blind (assessor blind), randomised controlled group study. It will take place in the NHS hospital setting. Stratification will be performed for age and sex by means of a minimisation technique during randomisation for each subject entering the trial. Any participant that withdraws from the study will be replaced.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2022

First Posted

August 18, 2022

Study Start

April 6, 2021

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

September 8, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations